Lymphoma, Extranodal NK-T-Cell

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Neoplasms

Treatments and conditions

Lymphoma, Extranodal NK-T-Cell
Treatment and conditionWhere it standsTrials
Dibotatug for lymphoma, extranodal nk-t-cellPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Selinexor, anti-PD-1 antibody plus Golidocitinib for lymphoma, extranodal nk-t-cellTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
XPO1 inhibitor for lymphoma, extranodal nk-t-cellTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.